Bolt Biotherapeutics(DE:6LP0)
€5.180.00 (0.00%)
DE:6LP0
Bolt Biotherapeutics earnings date
€5.18
At close:0.00 (0.00%)
Bolt Biotherapeutics (6LP0) Q2 2026 Earnings Report
0 Followers
DE:6LP0 Q2 2026 EPS Results
- Actual EPS
- -EUR 4.15
- Consensus EPS
- -EUR 3.07
- Beat/Miss
- Missed by -EUR 1.07
- One Year Ago EPS
- -EUR 4.05
DE:6LP0 Q2 2026 Revenue Results
- Actual Revenue
- EUR 4,535.752
- Expected Revenue
- EUR 453.58K
- Beat/Miss
- Missed by -EUR 449.04K
- YoY Revenue Growth
- -99.72%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- After Close
- Conference Call
- Tuesday, August 11, 2026
DE:6LP0 Upcoming Earnings
Bolt Biotherapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6LP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -3.49- | -3.48 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -3.34-2.04 | -3.37 | 39.52% (+1.33) | |
| Aug 11, 2026 | 2026 (Q2) | -3.07-4.15 | -4.05 | -2.47% (-0.10) | |
| May 12, 2026 | 2026 (Q1) | -2.59-3.91 | -5.26 | 25.69% (+1.35) | |
| Mar 12, 2026 | 2025 (Q4) | -5.54-3.48 | -7.62 | 54.29% (+4.14) | |
| Nov 12, 2025 | 2025 (Q3) | -5.15-3.37 | -7.26 | 53.50% (+3.88) | |
| Aug 14, 2025 | 2025 (Q2) | -5.72-4.05 | -10.16 | 60.18% (+6.11) | |
| May 12, 2025 | 2025 (Q1) | -6.44-5.26 | -5.08 | -3.57% (-0.18) | |
| Mar 24, 2025 | 2024 (Q4) | -6.89-7.62 | -8.53 | 10.64% (+0.91) | |
| Nov 12, 2024 | 2024 (Q3) | -6.17-7.26 | -7.8 | 6.98% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

